JAN 26, 2016 11:03 AM PST

Protective Autophagy in Regulatory T Cells

WRITTEN BY: Kara Marker
Acting alongside T helper cells, the all-stars of adaptive immunity, regulatory T cells work to suppress any “potentially deleterious” T helper cell activities that could lead to an autoimmune disorder (Scandinavian Journal of Immunology). T helper cells activate effector immune cells to attack invading pathogens and abnormally growing cells, which is a good thing. However, these lymphocytes can also make mistakes and wrongly target the body’s own cells. This is where regulatory T cells come into play, protecting the body by maintaining self-tolerance and preventing allergic responses.
 
With regulatory T cells at the ready to keep the body’s immune system from attacking itself, other immune cells are free to concentrate on attacking pathogens and killing cancerous cells. However, what happens when the regulatory T cells themselves need protecting?
 
A regulatory T cell (blue) interacting with bacteria (green)

A new study published in Nature Immunology by scientists from St. Jude Children’s Research Hospital investigated the protective mechanisms of regulatory T cells. Like a doctor who helps treat and prevent other people from getting sick, regulatory T cells also depend on certain cellular processes to continue normal function, similar to how doctors wear masks, gloves, and wash their hands when with a patient.
 
"Regulatory T cells are very specialized cells that require activation to perform their function in curtailing undesirable immune responses," said study leader Hongbo Chi, PhD.
 
After being activated, a process called “autophagy” relieves regulatory T cells of “molecular garbage” that piles up in the cell. Imaging studies done from colon cancer cells in Chi’s experiments proved the necessity of autophagy for regulatory T cell function. Next, the team looked at mice models of disease to see how organisms respond as a whole when the process of autophagy was disturbed. Key genes for autophagy, Atg5 and Atg7, were deleted, and they saw regulatory T cell malfunction as expected in these knock-out mice.
 
Activated regulatory T cells without functional autophagy experienced excessive cell death and a “loss of identity,” a phrase Chi used to describe their non-regulatory T cell action that occurred without autophagy. Thus, after losing their traditional abilities and gaining new ones, the regulatory T cell population in the knock-out mice were actually able to clear tumors better than control mice.
 
"From this perspective, targeting autophagy could act in synergy with strategies that block autophagy in tumor cells for added benefits in cancer therapy," Chi said.
 
He and his team plan to study other tumor cell types with autophagy inhibition in regulatory T cells, focusing on the “detailed biochemical mechanisms” behind the protective mechanism of autophagy for regulatory T cells. The potential for new immunotherapies for cancer to be derived from this research is great, but Chi and his team have to ensure that upsetting the protective function of regulatory T cells does not create dangerous backlash for cancer patients.
 

Source: St. Jude Children’s Research Hospital
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 14, 2019
Immunology
NOV 14, 2019
When the Cell Dials 9-1-1
Researchers can now explain how a cell that is being attacked by bacteria or viruses specifically manages to 'sound the alarm'...
NOV 14, 2019
Health & Medicine
NOV 14, 2019
European Respiratory Society Task Force Sarcoidosis Patient Survey
Sarcoidosis is a rare, granulomatous disease that is found in the lungs of 90% of people diagnosed, but it can affect any organ in the body. More than 2/3 ...
NOV 14, 2019
Cancer
NOV 14, 2019
Widely Prescribed Breast Cancer Medication Promotes Metastasis
The primary goals of metastatic breast cancer treatment are to ensure that the patient has the longest survival possible while experiencing the highes...
NOV 14, 2019
Microbiology
NOV 14, 2019
Dengue Vaccine Reaches the Clinic, with Restrictions
Dengue fever is an unusual virus that presented complications for the recently-developed and first vaccine for the disease....
NOV 14, 2019
Cell & Molecular Biology
NOV 14, 2019
Understanding and Treating the Mechanisms That Drive Rheumatoid Arthritis
In RA, cells of the immune system mistakenly attack the joints, and cause the painful inflammation that is a hallmark of the disease....
NOV 14, 2019
Drug Discovery & Development
NOV 14, 2019
Novel Therapeutic For Eradicating The Flu Virus
Public Health officials have long warned about pandemic pathogens flying fast around the world. One virus already spreads across the globe annually leading...
Loading Comments...